Fenimore Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,050
Closed -$726K 100
2023
Q3
$726K Sell
7,050
-10
-0.1% -$1.08K 0.02% 81
2023
Q2
$815K Hold
7,060
0.02% 82
2023
Q1
$751K Sell
7,060
-545
-7% -$58.8K 0.02% 81
2022
Q4
$844K Hold
7,605
0.02% 85
2022
Q3
$655K Hold
7,605
0.02% 88
2022
Q2
$693K Buy
7,605
+70
+0.9% +$6.21K 0.02% 89
2022
Q1
$618K Hold
7,535
0.02% 91
2021
Q4
$577K Sell
7,535
-113
-1% -$9K 0.01% 93
2021
Q3
$574K Sell
7,648
-187
-2% -$14.2K 0.01% 90
2021
Q2
$609K Sell
7,835
-376
-5% -$28K 0.01% 94
2021
Q1
$604K Sell
8,211
-105
-1% -$7.75K 0.02% 91
2020
Q4
$649K Hold
8,316
0.02% 87
2020
Q3
$658K Hold
8,316
0.02% 84
2020
Q2
$614K Hold
8,316
0.02% 86
2020
Q1
$611K Buy
8,316
+618
+8% +$48.6K 0.02% 90
2019
Q4
$668K Hold
7,698
0.02% 87
2019
Q3
$618K Hold
7,698
0.02% 92
2019
Q2
$616K Buy
7,698
+58
+0.8% +$4.44K 0.02% 92
2019
Q1
$606K Hold
7,640
0.02% 92
2018
Q4
$557K Sell
7,640
-150
-2% -$10.6K 0.02% 93
2018
Q3
$527K Hold
7,790
0.02% 94
2018
Q2
$451K Sell
7,790
-28
-0.4% -$1.58K 0.02% 96
2018
Q1
$406K Hold
7,818
0.02% 94
2017
Q4
$420K Sell
7,818
-339
-4% -$18.8K 0.02% 96
2017
Q3
$498K Buy
+8,157
New +$495K 0.02% 91

Other funds holding MRK

Fenimore Asset Management's MRK Position: Q4 2023 in Review

Fenimore Asset Management sold out of Merck (MRK) in Q4 2023, closing a stake of 7,050 shares — an estimated $726K sold.

Fenimore Asset Management first reported a position in MRK in Q3 2017 and held it in 25 quarters. The position peaked at $844K in Q4 2022. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Fenimore Asset Management reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Fenimore Asset Management sold 7,050 Merck shares in Q4 2023, an estimated $726K.
  • Fenimore Asset Management first reported a position in Merck in Q3 2017 and held it in 25 quarters.
  • Fenimore Asset Management's Merck position peaked at $844K in Q4 2022.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Fenimore Asset Management's 13F filing for Q4 2023, filed 23 Jan 2024.